Page last updated: 2024-11-02

pentoxifylline and ER-Negative PR-Negative HER2-Negative Breast Cancer

pentoxifylline has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Pentoxifylline (PTXF) is a xanthine derivative that can modulate the nuclear factor kappa B (NF-κB) signaling and probably affect the Treg proportion in TILs."1.72Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model. ( Falak, R; Ghanavatinejad, A; Kazemi, MH; Khorrami, S; Momeni-Varposhti, Z; Sadeghi, B; Shokrollahi Barough, M, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Kazemi, MH2
Shokrollahi Barough, M2
Ghanavatinejad, A2
Momeni-Varposhti, Z2
Khorrami, S1
Sadeghi, B2
Falak, R2
Zarehzadeh Mehrabadi, A1
Castellanos-Esparza, YC1
Wu, S1
Huang, L1
Buquet, C1
Shen, R1
Sanchez-Gonzalez, B1
García Latorre, EA1
Boyer, O1
Varin, R1
Jiménez-Zamudio, LA1
Janin, A1
Vannier, JP1
Li, H1
Lu, H1

Other Studies

3 other studies available for pentoxifylline and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model.
    Iranian journal of allergy, asthma, and immunology, 2022, Apr-11, Volume: 21, Issue:2

    Topics: Animals; Disease Models, Animal; Humans; Lymphocytes, Tumor-Infiltrating; Mice; Pentoxifylline; T-Ly

2022
Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes.
    Medical oncology (Northwood, London, England), 2023, May-06, Volume: 40, Issue:6

    Topics: Animals; Antineoplastic Agents; Forkhead Transcription Factors; Humans; Lymphocytes, Tumor-Infiltrat

2023
Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells.
    International journal of oncology, 2018, Volume: 52, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line, Tumor; Cell Prolife

2018